Analyze Diet
Equine veterinary journal. Supplement1992; (11); 66-68; doi: 10.1111/j.2042-3306.1992.tb04777.x

Sympatho-adrenal activity and the clinical sedative effect of detomidine in horses.

Abstract: Thirty-nine horses were given detomidine 10 micrograms/kg bodyweight (bwt) intravenously (iv) and six horses were given a corresponding volume of saline solution before minor procedures. Venous blood samples were collected for catecholamine and cortisol determination immediately before the detomidine or saline injection and 20 mins after it. The behaviour of the horse at the time of detomidine injection and the extent of sedation were evaluated. Plasma adrenaline, noradrenaline and the catecholamine metabolites, 3,4-dihydroxyphenylglycol (DHPG) and 3,4-dihydroxyphenylacetic acid (DOPAC), and cortisol concentrations decreased significantly after administration of detomidine, but they remained unchanged in the control group. A high plasma adrenaline concentration before detomidine injection, indicative of a high level of stress, seemed to correspond with a reduced sedative effect of detomidine. The extent of sedation also was related to the concentrations of adrenaline, noradrenaline and DHPG in plasma after the detomidine injection. The reductions in the plasma catecholamine concentrations may have been caused, in part, by decreased secretion of catecholamines due to the sedative effects of detomidine; but detomidine also influences the plasma catecholamine concentrations by reducing directly sympatho-adrenal activity.
Publication Date: 1992-02-01 PubMed ID: 9109965DOI: 10.1111/j.2042-3306.1992.tb04777.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Controlled Clinical Trial
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigated how the sedative drug detomidine affects the behavior and certain hormone levels in horses. Results showed that detomidine significantly reduced stress hormones and their metabolites, with higher initial stress levels corresponding to reduced sedative effects.

Study Context and Design

  • The study involved forty-five horses, with thirty-nine of them receiving an intravenous injection of detomidine, a sedative drug, while the other six received saline as a control group.
  • This was done prior to minor procedures, and then blood samples were collected immediately before and 20 minutes after the treatment to measure hormone levels.
  • The behavior of each horse and the degree of sedation were observed and recorded at the time of detomidine injection.

Impact of Detomidine on Hormone Levels

  • The researchers found that administration of detomidine led to a significant decrease in the following substances in the horses’ blood: adrenaline, noradrenaline (both stress hormones), two derivatives of these hormones (DHPG and DOPAC), and cortisol (another stress hormone).
  • In contrast, these measures remained constant in the control group that received the saline injection instead of detomidine.

Initial Stress Levels and Sedative Effectiveness

  • The researchers also noted that horses with higher adrenaline levels before receiving the detomidine injection, exhibited a diminished sedative effect. This indicates a correlation between an animal’s initial stress level and the effectiveness of a sedative drug.

The Role of Catecholamines in Sedation

  • The study also found a relationship between the degree of sedation and the concentrations of adrenaline, noradrenaline and DHPG in plasma after detomidine injection.
  • The reduction in levels of these hormones might have been partially caused by decreased secretion due to the calming effects of detomidine. However, the researchers suggest that detomidine might also act directly on sympatho-adrenal activity, leading to a decrease in catecholamine levels.

In conclusion, detomidine affects both hormone levels and sedative effectiveness in horses, with intial stress levels also playing a significant role in the sedative’s effectiveness.

Cite This Article

APA
Raekallio M, Leino A, Vainio O, Scheinin M. (1992). Sympatho-adrenal activity and the clinical sedative effect of detomidine in horses. Equine Vet J Suppl(11), 66-68. https://doi.org/10.1111/j.2042-3306.1992.tb04777.x

Publication

NlmUniqueID: 9614088
Country: United States
Language: English
Issue: 11
Pages: 66-68

Researcher Affiliations

Raekallio, M
  • College of Veterinary Medicine, Department of Clinical Sciences, Helsinki, Finland.
Leino, A
    Vainio, O
      Scheinin, M

        MeSH Terms

        • 3,4-Dihydroxyphenylacetic Acid / blood
        • Adrenal Glands / drug effects
        • Analysis of Variance
        • Animals
        • Blood Specimen Collection / veterinary
        • Chromatography, High Pressure Liquid
        • Epinephrine / blood
        • Female
        • Heart Rate / drug effects
        • Horses / physiology
        • Hypnotics and Sedatives / administration & dosage
        • Hypnotics and Sedatives / pharmacology
        • Imidazoles / administration & dosage
        • Imidazoles / pharmacology
        • Injections, Intravenous / veterinary
        • Male
        • Methoxyhydroxyphenylglycol / analogs & derivatives
        • Methoxyhydroxyphenylglycol / blood
        • Norepinephrine / blood
        • Saline Solution, Hypertonic / administration & dosage
        • Sympathetic Nervous System / drug effects

        Citations

        This article has been cited 6 times.
        1. Gehlen H, Jaburg N, Merle R, Winter J. Can Endocrine Dysfunction Be Reliably Tested in Aged Horses That Are Experiencing Pain?. Animals (Basel) 2020 Aug 14;10(8).
          doi: 10.3390/ani10081426pubmed: 32824027google scholar: lookup
        2. Pakkanen SAE, de Vries A, Raekallio MR, Mykkänen AK, Palviainen MJ, Sankari SM, Vainio OM. Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan.. Acta Vet Scand 2018 May 9;60(1):27.
          doi: 10.1186/s13028-018-0380-xpubmed: 29743097google scholar: lookup
        3. Müller TM, Hopster K, Bienert-Zeit A, Rohn K, Kästner SBR. Effect of butorphanol, midazolam or ketamine on romifidine based sedation in horses during standing cheek tooth removal.. BMC Vet Res 2017 Dec 6;13(1):381.
          doi: 10.1186/s12917-017-1299-6pubmed: 29212478google scholar: lookup
        4. Arnemo JM, Moe SR, Søli NE. Xylazine-induced sedation in axis deer (Axis axis) and its reversal by atipamezole.. Vet Res Commun 1993;17(2):123-8.
          doi: 10.1007/BF01839240pubmed: 8105603google scholar: lookup
        5. Arnemo JM, Søli NE. Chemical capture of free-ranging cattle: immobilization with xylazine or medetomidine, and reversal with atipamezole.. Vet Res Commun 1993;17(6):469-77.
          doi: 10.1007/BF01839214pubmed: 7913274google scholar: lookup
        6. Arnemo JM, Søli NE. Reversal of xylazine-induced sedation in dairy calves with atipamezole: a field trial.. Vet Res Commun 1993;17(4):305-12.
          doi: 10.1007/BF01839221pubmed: 7908472google scholar: lookup